- 7025 malaria professionals are enjoying the free benefits of MalariaWorld today
Roll Back Malaria
Wide-scale trial of malaria vaccine produces promising results
First results from a large-scale Phase III trial of RTS,S, published online yesterday in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile...
Categories: Roll Back Malaria
Global Atlas echoes findings from RBM's latest report on elimination
A global atlas charts prospects for malaria elimination and offers a visual tool to help focus resources where they are needed most....
Categories: Roll Back Malaria
Eliminating Malaria: Learning from the Past, Looking Ahead
Eliminating Malaria: Learning from the Past, Looking Ahead, the eighth report in the Roll Back Malaria Progress and Impact Series, details previous malaria elimination and eradication efforts to date, and summarizes ongoing progress in all malaria-endemic areas of the world...
Categories: Roll Back Malaria
Nearly a third of all malaria affected countries on course for elimination over the next decade
A new report released by the Roll Back Malaria Partnership (RBM) just prior to the opening of the Bill and Melinda Gates Foundation Malaria Forum in Seattle, reveals that an increasing number of countries are setting their sights on eliminating malaria, with three countries already certified as malaria-free by the World Health Organization (WHO) in the last 4 years...
Categories: Roll Back Malaria
RBM Support to Global Fund Round 11 Malaria Proposal Development
As a result of the expected delay in availability of resources, the Global Fund Board has extended the application deadline for Round 11, the Second Wave of NSAs and HSFP applications until at least 1 March 2012. ...
Categories: Roll Back Malaria
